[ Anglais] ESMO 2017 Breast Cancer Research Update

Published on

Topics include: Understanding

Dr. Giuseppe Curigliano, breast cancer and drugs researcher at Istituto Europeo di Oncologia (Milan, Italy), gives us an update of the most exciting breast cancer studies presented at the European Medical Oncology Congress (ESMO) held in Madrid in September 2017. He includes new information on the metastatic breast cancer Monarch 3 Trial.

This interview was recorded at the European Society of Medical Oncology (ESMO) congress held in Madrid (September 2017). Breast cancer videos recorded at ESMO 17 are part of an educational program by the Patient Empowerment Foundation (PEF). We thank Roche for their support.


View more programs featuring

Related Programs

How Can Genomic Profiling Benefit Breast Cancer Patients?

What is the role of genomic profiling in breast cancer? Dr. Giuseppe Curigliano explains why genomic profiling can be beneficial to patients.


Rejoignez notre communauté S'inscrire aux événements Lisez notre dernier blog

Page last updated on September 26, 2017